Condition

Multidrug-Resistant Pulmonary Tuberculosis clinical trials and research

• 2Clinical trials
• 10Countries

All recruiting trials (2)

• Quabodepistat-containing regimens for drug-resistant pulmonary tuberculosis

  This will test whether quabodepistat combined with other TB drugs can shorten treatment and be safer for adults and teens with rifampicin-resistant or multidrug-resistant pulmonary TB.

  Recruiting at 33 sites Phase 3 Otsuka Pharmaceutical Development & Commercialization, Inc. · Beijing, Beijing Municipality and 41 other locations · NCT07209761

• JDB0131 tablets for drug-resistant pulmonary TB

  This tests two doses of the experimental tablet JDB0131 versus a delamanid-containing regimen in people aged 14–65 with rifampicin-resistant or multidrug-resistant pulmonary tuberculosis over an 8-week treatment period.

  Recruiting at 6 sites Phase 2 WestVac Biopharma Co., Ltd. · Wuhan, Hubei and 6 other locations · NCT07170800

Related topics

Quick answers

How many Multidrug-Resistant Pulmonary Tuberculosis clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in China (2 trials), Georgia (1 trial), India (1 trial), Indonesia (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →